SURG 5100 — recruitment poster

SURG 5100
Biopharmaceutical
Drug Development
Fall 2026
3 credits
CRN 96270

Of a hundred programs that start, two reach a patient.

This course is about the ninety-eight — where they stopped, what it cost, and which decision would have caught it a year earlier.

Taught with industry
Matt Whelihan, PhD
Research & Development · Prolytix Technologies
A working industry scientist in the room every week — not a guest lecture.
with Dev Majumdar, PhD · Larner College of Medicine & Biomedical Engineering
  • 01Site visits to Vermont pharmaceutical and biotechnology operations.
  • 02Founders and CEOs as guests, with quality and regulatory leads who file with the FDA.
  • 03Undergraduates and graduate students in the same room.
✓ Elective credit, most departments
✓ All levels
ask your advisor how it
applies to your program

Tuesday & Thursday, 11:40 a.m. – 12:55 p.m.
University of Vermont · uvm5100.pages.dev

Syllabus &
full schedule